Skip to content

RNTX RNTX Quick ratio

Quick ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.3×+0.1×
Gilead Sciences logo
Gilead SciencesGILD
1.7×+0.5×
AbbVie logo
AbbVieABBV
0.7×0.0×
CTO
Citius Oncology, Inc.CTOR
0.1×+0.1×
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
5.8×-2.0×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
4.1×+0.9×

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on the most recent quarter.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's quick ratio?
RNTX (RNTX) reported quick ratio of 0.4× in Q1 2026.
How has RNTX's quick ratio changed year-over-year?
RNTX's quick ratio decreased by 71.3% year-over-year, from 1.4× to 0.4×.
What is the long-term trend for RNTX's quick ratio?
Over 5 years (2020 to 2025), RNTX's quick ratio has grown at a -29.9% compound annual growth rate (CAGR), from 4.1× to 0.7×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.